Issue of Debate at C3, June 17-20, 2018 Interventional Academy Speaks with Prof David Erlinge, MD, PhD, FESC, FACC, Head, Department of Cardiology, Lund, Sweden Treatment with dual antiplatelet therapy
More Controversy About the Role of a PFO in Stroke? by Bryan Kluck Recently, three publications have fundamentally changed the paradigm in approaching patients with cryptogenic stroke. The Extended RESPECT,
AHA/ASA expands treatment window for percutaneous thrombectomy window to 24 hours in a newly released guideline at International Stroke Conference. The recommendation was based on DAWN & DEFUSE 3 trials.
